ACCESSIBILITY

24/7

Headlines

20:15

Payoneer cuts 6% of workforce as profitability pressures mount

20:04

Johny Srouji breaks silence: “I don’t plan on leaving Apple anytime soon”

16:00

Israeli cybersecurity funding soars to $4.4 billion, up 46% in 2025

15:08

“ My main argument for Israeli startups to come to Europe is it's a huge market”

Buzz

Most popular

Daily

Weekly

“I can retire… with peace”: Nir Zuk says Palo Alto Networks finally achieved his 20-year vision with $25B CyberArk acquisition

Mobileye lays off 200 employees; Company's shares down more than 40% this year

ZIM faces pivotal vote as company weighs at least three acquisition offers

Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program

Nice puts Actimize up for sale at a $1.5-2 billion price tag

More news

IPO

20 stories about IPO

CEO of Israeli E-commerce Group Resigns after Failed Tel Aviv IPO Attempt

28.10.18|Adi Pick

Ilan Tzachi, CEO OF Zap Group, announced on Sunday his intention to resign, concluding his tenure in January 2019

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18|Lilach Baumer

The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share

LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO

21.10.18|Lilach Baumer

Co-founded by Israel-born Adi Barzel, LogicBio develops genome-editing treatments for rare diseases

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18|Lilach Baumer

The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms

IT and Analytics Company Elastic Catapults on NYSE IPO

07.10.18|Meir Orbach

The Israel-linked company closed 94% up on its first trading day, after raising $252 million at above the original prospectus price

Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO

30.09.18|Dror Reich

The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution

Communication Equipment Firm ECI Confirms Plans for London IPO

20.09.18|Golan Hazani

ECI seeks to raise around $230 million in new and existing shares, according to the company’s registration documents

Israel to Privatize National Postal Company

06.08.18|Zvi Zerahia

On Sunday, a parliamentary committee approved a decision to sell 40% of the company to strategic investors and the public. 60% will remain state-owned

Medical Device Company Medigus Raises $10 Million in Public Offering

24.07.18|CTech

Medigus develops minimally invasive endosurgical tools and direct visualization technology

As Market Matures, Israeli Tech Exits Continue to Diminish, Report Says

11.07.18|Hagar Ravet

The downward trend in the number of exits in Israel since 2015 continues, with 58 deals recorded between January and June 2018, compared to 63 deals in the first half of 2017

Cybersecurity Company Safe-T Group Submits Preliminary Prospectus for Nasdaq IPO

08.07.18|Lilach Baumer

The company is currently listed on the Tel Aviv Stock Exchange and on the OTCQB venture market

מימין מנכ"ל ThetaRay מארק גזית והמנהל שותף של JVP יואב צרויה

Cybersecurity Company ThetaRay Raises $30 Million

03.07.18|Golan Hazani

Founded in 2013, ThetaRay uses machine learning algorithms to detect system behavior anomalies and threats such as ATM hacking, insurance fraud, and SWIFT-based attacks

CTech's Sunday Roundup of Israeli Tech News

01.07.18|CTech

The Israeli military has big plans for small drones. Volkswagen sees blockchain-enabled cars in Its future.

Fourth Time’s the Charm for Entera Bio IPO

01.07.18|Dror Reich

The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich

This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq

Cellular Services Company Celltick Plans Tel Aviv IPO to Finance Growth

07.05.18|Amir Rosenbaum

The company is looking to raise up to $15 million, listing 15% of its existing shares

Nasdaq-Listed Diabetes Monitoring Company Dario Considering Dual Tel Aviv Registration

03.05.18|Golan Hazani

Dario develops a device that enables users to test and track their blood-glucose levels in real time using their smartphones

Attempting to Delist, Cancer Treatment Company BioCanCell Issues New Shares

23.04.18|Dror Reich

The company diluted existing investors that opposed its plans to delist from the Tel Aviv Stock Exchange

Israeli Surveillance Company Verint Considers an IPO for its Security Intelligence Division

28.03.18|Golan Hazani

After a failed attempt to sell the division, Verint mulls an IPO of the sub-unit according to a market value of $800 million

CTech’s Sunday Roundup of Israeli Tech News

25.03.18|CTech

U.S. court charges Israeli CEO with binary options fraud. Stock market downturn leads biotech company Polypid to backtrack on IPO

Previous Articles More Articles